InvestorsHub Logo

BioInvestor4

07/04/20 7:09 PM

#90814 RE: SilverKnightLV #90806

There is plenty of room for multiple therapeutics. No single company can supply anywhere near enough of what is needed.

ohm20

07/04/20 10:34 PM

#90866 RE: SilverKnightLV #90806

Which drug is better? One that controls GM-CSF or one that controls GM-CSF and a wide range of other factors? It would definitely be the latter, which would be leronlimab.

Venture_Cap

07/05/20 12:23 AM

#90904 RE: SilverKnightLV #90806

Neither but will be all at some point. Long race